Related Experiment Video
Updated: Aug 18, 2025
Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Cardiovascular Risk Prediction in Chronic Kidney Disease
Xiejia Li1,2, Bengt Lindholm3
1Department of Nephrology, The Second Xiangya Hospital, Central South University, Changsha, China, lixiejia1218@csu.edu.cn.
Insights
Cardiovascular disease (CVD) is a major complication for chronic kidney disease (CKD) patients. Accurate CVD risk prediction models are crucial for timely interventions and improved patient outcomes.
Area of Science:
- Nephrology
- Cardiology
- Public Health
Background:
- Cardiovascular disease (CVD) is a significant complication in chronic kidney disease (CKD) patients.
- CVD risk is elevated even in early CKD stages, with CVD deaths comprising 50% of mortality in end-stage renal disease.
- Accurate CVD risk prediction is essential for identifying high-risk CKD individuals for intensive management.
Purpose of the Study:
- To review the applicability and performance of existing cardiovascular risk prediction tools in CKD patients.
- To highlight the need for novel CVD risk biomarkers and improved predictive models tailored for CKD populations.
Main Methods:
- Literature review of cardiovascular risk prediction tools.
- Analysis of model performance in CKD populations.
- Discussion of current challenges and future directions in CKD CVD risk assessment.
Main Results:
- General population CVD risk models demonstrate suboptimal performance in CKD patients.
- There is a growing interest in developing CKD-specific CVD risk biomarkers and predictive models.
- Continued research is needed to refine risk assessment strategies for CKD patients.
Conclusions:
- Cardiovascular risk prediction in CKD requires dedicated research and attention.
- Improved risk prediction models are vital for guiding clinical interventions and enhancing patient prognosis.
- The development of CKD-adapted risk assessment tools is a priority for clinical practice.
Background:
As one of the main complications of chronic kidney disease (CKD), the incidence of cardiovascular disease (CVD) in CKD patients is high. CVD risk is markedly increased even at early stages of CKD, and CVD deaths account for half of all known causes of mortality in end-stage renal disease patients. The alarming rate of CVD in CKD patients demands accurate risk prediction to identify individuals at greater risk and therefore needing intensive surveillance and treatment in order to improve their prognosis.
Summary:
Since the CVD risk prediction models used in general population did not perform well in CKD patients, novel CVD risk biomarkers and improved risk predictive models adapted to CKD are receiving increasing attention in recent years. In this article, we review the applicability and performance of some of the available cardiovascular risk prediction tools in CKD.
Key Messages:
Cardiovascular risk prediction in CKD needs and deserves continued attention and in-depth research that helps clinicians set out timely and effective interventions.
Related Concept Videos
01:25Chronic Kidney Disease I: Introduction
01:18Chronic Kidney Disease IV: Nursing Management
01:28Chronic Kidney Disease III: Interprofessional Care
01:24Chronic Kidney Disease II: Clinical Manifestations
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
01:17Factors Affecting Renal Clearance: Renal Impairment
One condition associated with renal failure is uremia. Uremia is characterized by impaired glomerular filtration and fluid accumulation in the body. This condition hinders the renal clearance of drugs, resulting in drug accumulation and potential...